Literature DB >> 20691553

Comparison of AngioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction. The JETSTENT trial.

Angela Migliorini1, Amerigo Stabile, Alfredo E Rodriguez, Caterina Gandolfo, Alfredo M Rodriguez Granillo, Renato Valenti, Guido Parodi, Franz-Josef Neumann, Antonio Colombo, David Antoniucci.   

Abstract

OBJECTIVES: The aim of this study was to determine whether rheolytic thrombectomy (RT) before direct infarct artery stenting as compared with direct stenting (DS) alone results in improved myocardial reperfusion and clinical outcome in patients with acute myocardial infarction.
BACKGROUND: The routine removal of thrombus before infarct artery stenting is still a matter of debate.
METHODS: This is a multicenter, international, randomized, 2-arm, prospective study. Eligible patients were patients with acute myocardial infarction, angiographic evidence of thrombus grade 3 to 5, and a reference vessel diameter ≥2.5 mm. Coprimary end points were early ST-segment resolution and (99m)Tc-sestamibi infarct size. An α value = 0.05 achieved by both coprimary surrogate end points or an α value = 0.025 for a single primary surrogate end point would be considered evidence of statistical significance. Other surrogate end points were Thrombolysis In Myocardial Infarction (TIMI) flow grade 3, corrected TIMI frame count, and TIMI grade 3 blush. Clinical end points were a composite of major adverse cardiovascular events at 1, 6, and 12 months.
RESULTS: From December 2005 to September 2009, 501 patients were randomly allocated to RT before DS or to DS alone. The ST-segment resolution was more frequent in the RT arm as compared with the DS alone arm: 85.8% and 78.8%, respectively (p = 0.043), while no difference between groups were revealed in the other surrogate end points. The 6-month major adverse cardiovascular events rate was 11.2% in the thrombectomy arm and 19.4% in the DS alone arm (p = 0.011). The 1-year event-free survival rates were 85.2 ± 2.3% for the RT arm, and 75.0 ± 3.1% for the DS alone arm (p = 0.009).
CONCLUSIONS: Although the primary efficacy end points were not met, the results of this study support the use of RT before infarct artery stenting in patients with acute myocardial infarction and evidence of coronary thrombus. (AngioJet Rheolytic Thrombectomy Before Direct Infarct Artery Stenting in Patients Undergoing Primary PCI for Acute Myocardial Infarction [JETSTENT]; NCT00275990).
Copyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20691553     DOI: 10.1016/j.jacc.2010.06.011

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  26 in total

1.  Manual vs mechanical thrombectomy during PCI for STEMI: a comprehensive direct and adjusted indirect meta-analysis of randomized trials.

Authors:  Eliano Pio Navarese; Giuseppe Tarantini; Giuseppe Musumeci; Massimo Napodano; Roberta Rossini; Mariusz Kowalewski; Anna Szczesniak; Michalina Kołodziejczak; Jacek Kubica
Journal:  Am J Cardiovasc Dis       Date:  2013-08-16

Review 2.  The management of thrombotic lesions in the cardiac catheterization laboratory.

Authors:  Fadi Matar; Jad Mroue
Journal:  J Cardiovasc Transl Res       Date:  2011-10-21       Impact factor: 4.132

3.  Manual Aspiration Thrombectomy in Acute Myocardial Infarction: A Clinical Experience.

Authors:  Abhishek Jaiswal; Simcha Pollack; Astha Chichra; Emmanuel Moustakakis; Chong Park; Todd Kerwin
Journal:  Int J Angiol       Date:  2015-03-23

Review 4.  [Thrombus aspiration in patients with acute myocardial infarction : Scientific evidence and guideline recommendations].

Authors:  T Stiermaier; S de Waha; G Fürnau; I Eitel; H Thiele; S Desch
Journal:  Herz       Date:  2016-03-15       Impact factor: 1.443

5.  Use of Thrombectomy Devices in Primary Percutaneous Interventions for ST-elevation Myocardial Infarction - An Update.

Authors:  Krishnaraj S Rathod; Stephen M Hamshere; Tawfiq R Choudhury; Daniel A Jones; Anthony Mathur
Journal:  Interv Cardiol       Date:  2014-04

6.  Evidence for a novel racemization process of an asparaginyl residue in mouse lysozyme under physiological conditions.

Authors:  K Ueno; T Ueda; K Sakai; Y Abe; N Hamasaki; M Okamoto; T Imoto
Journal:  Cell Mol Life Sci       Date:  2005-01       Impact factor: 9.261

Review 7.  Thrombus aspiration in acute myocardial infarction: Rationale and indication.

Authors:  Gennaro Sardella; Rocco Edoardo Stio
Journal:  World J Cardiol       Date:  2014-09-26

Review 8.  Thrombus aspiration in acute myocardial infarction.

Authors:  Karim D Mahmoud; Felix Zijlstra
Journal:  Nat Rev Cardiol       Date:  2016-03-10       Impact factor: 32.419

Review 9.  Thrombus aspiration in primary angioplasty for ST-segment elevation myocardial infarction.

Authors:  Roberta Serdoz; Michele Pighi; Nikolaos V Konstantinidis; Ismail Dogu Kilic; Sara Abou-Sherif; Carlo Di Mario
Journal:  Curr Atheroscler Rep       Date:  2014-08       Impact factor: 5.113

Review 10.  Treating thrombus in the coronary arteries.

Authors:  B Boztosun; R D Acar
Journal:  Herz       Date:  2013-08-08       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.